This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.". Issue 3 (12th February 2018)
Record Type:
Journal Article
Title:
Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.". Issue 3 (12th February 2018)
Main Title:
Do we have enough evidence for recommending therapeutic apheresis for natalizumab‐related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice‐evidence‐based approach from the Writing Committee of the American Society for apheresis: The seventh special issue."